Nephrotoxic Effects of Primary Immunosuppression With FK-506 and Cyclosporine Regimens After Liver Transplantation
Authors:
- Stephen C. TextorSTStephen C. Textor
- Ruud A.F. KromRKRuud A.F. Krom
- J. Eileen HayJHJ. Eileen Hay
- Gregory J. GoresGGGregory J. Gores
- Teresa M. RichardsTRTeresa M. Richards
- Paula H. CrottyPCPaula H. Crotty
- Sandra J. BeaverSBSandra J. Beaver
- Jeffery L. SteersJSJeffery L. Steers
- Russell H. WiesnerRWRussell H. Wiesner
- 1 February 1994
- journal article
- clinical trial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 69 (2) , 105-111
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- THE EFFECT OF GRAFT FUNCTION ON FK506 PLASMA LEVELS, DOSAGES, AND RENAL FUNCTION, WITH PARTICULAR REFERENCE TO THE LIVERTransplantation, 1991
- ELEVATION OF PLASMA ENDOTHELIN ASSOCIATED WITH SYSTEMIC HYPERTENSION IN HUMANS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1991
- Acute and Chronic Renal Failure in Liver TransplantationNephron, 1990
- The Spectrum of Ciclosporin NephrotoxicityAmerican Journal of Nephrology, 1990
- FK-506 — How much potential?Immunology Today, 1989
- Limitations of Creatinine in Quantifying the Severity of Cyclosporine-Induced Chronic NephropathyAmerican Journal of Kidney Diseases, 1986
- NEPHROTOXICITY OF PARENTERALLY ADMINISTERED CYCLOSPORINE AFTER ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1983